IndraLab

Statements

Tacrolimus (anhydrous) inhibits KCNK18. 3 / 3
| 3
reach
"Therefore, Cyclosporine A and FK506, immunosuppressive compounds, which are calcineurin inhibitors widely used as immunosuppressors in the clinic, prevent TRESK activation."
23200789
reach
"In the present study, we found that the selective calcineurin inhibitor FK506 prevented TRESK activation in HEK293 cells."
22145024
reach
"Cyclosporin A and FK506, specific inhibitors of the calcium/calmodulin dependent protein phosphatase (calcineurin), completely eliminated TRESK activation."
14981085